General Discussions
People often ask oncology nurses, "Isn't your job depressing?" Angee Kilmer, BSN, RN-BC, nursing supervisor of radiation oncology for the University of Kansas Cancer Centers and contr...
This is the good though to spread the medicines across many other places to all patients. As per kibin survey this will definitely help in curing the particular illness and increase the stamina in ...
Interventions to reduce the pain of port access should be considered, especially in patients who have a low pain threshold. Several types of anesthetics are available including topical, injectable...
The treatment of patients with advanced non-small cell lung cancer (NSCLC) has drastically changed within recent years, thanks to the advent of targeted therapy and immunotherapy. Chemotherapy also...
A majority of adult patients with β-thalassemia who require regular red blood cell (RBC) transfusions experienced clinically meaningful and durable transfusion burden reduction associated with...
In December 2019, the Food and Drug Administration (FDA) approved olaparib (Lynparza) for the frontline maintenance treatment of patients with BRCA-positive pancreatic cancer. This was a major ad...
Kathleen Madden, MSN, RN, APHN, AOCNP, FNP-BC, a nurse practitioner at NYU Langone Health's Perlmutter Cancer Center, offers nurses and other providers advice on detecting and discussing adve...
The FDA granted a priority review to belantamab mafodotin for the treatment of heavily pre-treated patients with relapsed or refractory multiple myeloma, according to GlaxoSmithKline.1 With this, ...
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.